Higher levels of systemic α-chemokines (MIG and IP10) have been detected in HTLV-1-infected individuals with HAM/TSP or dermatological diseases compared to asymptomatic carriers [20,21]. The gene discussed is CXCL9; the disease is tropical spastic paraparesis.